- Award ID
- 75N93021C00018
- Sub-agency / office
- National Institutes of Health
- Award amount
- $24,554,515
- Period of performance
- Apr 1, 2021 – Jul 31, 2028
- Place of performance
- ATHENS, GA, 306025016, USA
- Competition
- FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 9 offers
- Pricing
- COST NO FEE
- Financial breakdown
- Current value $24,554,515 · Obligated $24,554,515 · Potential value $91,712,354 · Latest action obligation $-63,264 · Outlays $14,428,057
Most recent · Modification P00026 · Jul 29, 2026 · $-63,264 action obligation · EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00025 · Jul 7, 2026 · $0 action obligation · EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00024 · Apr 8, 2026 · $0 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00023 · Mar 25, 2026 · $1,658,412 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00022 · Dec 30, 2025 · $1,108,519 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00021 · Sep 23, 2025 · $600,000 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00020 · Aug 26, 2025 · $0 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00019 · Jun 25, 2025 · $851,901 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00018 · May 1, 2025 · $1,088,922 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018
Modification P00017 · Mar 14, 2025 · $189,355 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00016 · Mar 10, 2025 · $1,085,159 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00015 · Sep 20, 2024 · $3,381,348 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00014 · Jul 1, 2024 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00013 · May 30, 2024 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00012 · Apr 4, 2024 · $1,062,343 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00011 · Sep 6, 2023 · $4,947,018 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00010 · Aug 14, 2023 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00009 · Jul 5, 2023 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00008 · May 18, 2023 · $883,301 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00007 · Mar 29, 2023 · $1,040,373 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018
Modification P00006 · Sep 12, 2022 · $1,692,123 action obligation · THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 14, OPTION 18 AND OPTION 19.A. · 75N93021C00018
Modification P00005 · Mar 22, 2022 · $1,018,874 action obligation · THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE SEVERABLE OPTION 1 FOR $1,018,874.00 AND UPDATE OTHER ARTICLES AND CLAUSES. · 75N93021C00018
Modification P00004 · Feb 4, 2022 · $0 action obligation · IPP - CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE HHSAR 352.232-71 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS IN FULL TEXT AND PROVIDE INSTRUCTIONS FOR THE TRANSITION FROM THE NIH OFFICE OF FINANCIAL MAN · 75N93021C00018
Modification P00003 · Oct 13, 2021 · $0 action obligation · EO14042 CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS TO ADD FAR DEVIATION CLAUSE 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS. · 75N93021C00018
Modification P00002 · Aug 11, 2021 · $3,010,131 action obligation · CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS EXERCISE THREE (3) INSTANCES OF OPTION 11 AND ONE (1) INSTANCE OF OPTION 17, UPDATE PUBLICATION DISCLOSURE REQUIREMENTS IN ARTICLE F.2 DELIVERIES AND UPDATE VARIOUS ARTICLE · 75N93021C00018